Researchers have found evidence that is having an early supper or leaving at least two hours before going to bed are associated with a lower risk of developing breast and prostate cancer!
A recent study, published in the Lancet Oncology compared robotic to open prostate cancer surgery (prostatectomy). The study found that over a two-year period both forms of surgery produced equivalent results for preserving erectile function and urinary continence. However, there were some differences.
There are a number of items of news about state expansion of Medicaid, Family Leave and some attempts by certain states to screw their citizens who have cancer or chronic illnesses go around the federal medical insurance laws by
How radiation is delivered as a primary treatment for prostate cancer therapy has been changing, mostly since 2017. The change involves two different items, one the method of delivery of the radiation and the increasing use of a newly developed “safety” product that lowers the adverse side effects of the radiation treatment.
In a large study, it was found that men of African American (AA) descent who are candidates for active surveillance are not at an increased risk of being upstaged or upgraded at surgery compared to other men.
The men who received dose escalated radio therapy had less need for secondary therapies, but they did not have any survival advantage.
Researchers have concluded that high dose radiation therapy as a primary therapy does not improve survival. However, it does reduce PSA failures and the need to use salvage therapy.
A retrospective study reported about the benefits and late toxicity following an injection of a hydrogel spacer (HS) between the prostate and rectum for men treated with radiotherapy.
Having a very low PSA does not indicate that your prostate cancer is not aggressive.
Etna Insurance approves the use of SpaceOAR to protect men during their radiation treatments.
At last year’s American Society of Clinical Oncology GU Conference (ASCO-GU) researchers reported that men who took at least three aspirin tablets a week reduced their risk of developing or dying from advanced prostate cancer.
The European Union has recently placed some restrictions on the use of the MRI contrast agent Gadolinium.
The American Society of Clinical Oncology (ACSO), has declared that people drinking alcoholic drinks face a significantly increased risk of developing cancer(s).
The opinion of two Professionals in the know, - Gleason 9 and Gleason 10 prostate cancer is best treated by multiple modalities; surgery, radiation and hormone therapy used in combination.
The Prostate Health Index (phi) that is used to detect prostate cancer can limit the number of repeat biopsies that Urologists recommend. It also reduces the risk of over diagnosis, saves money and cuts down on the risk of biopsy-induced infections.
An article in the New York Times describes a new and more effective vaccine against Shingles, which you should consider getting.
Shingles can be a very painful and debilitating disease which most of us are at risk to get. The FDA has approved this new vaccine; Shingrix and it should be generally available within the next month.
There does seem to be an “ouch” factor involved in receiving the vaccine and it does require two separate injections, but getting Shingles is much worse.
We urge that you speak with your doctor and ask if you should be getting this vaccine. Having Shingles is no fun.
Joel T. Nowak, MA, MSW wrote this Post. Joel is the CEO/Executive Director of Cancer ABCs. He is a Cancer Thriver diagnosed with five primary cancers - Thyroid, Metastatic Prostate, Renal, Melanoma, and the rare cancer Appendiceal cancer.
If you have a recurrence of your prostate cancer after primary radiation therapy can a salvage radical prostatectomy (SRP) provide you with any benefits?
A study found that African American men had a higher rate of death from non-prostate cancer problems than non-African American men after receiving short-term hormone therapy (ADT) prior to having brachytherapy (seeds). There are significant implications beyond this research.
Five year data shows that Proton Beam Radiation may provide a better side effect profile and also reduce the risk of a prostate cancer recurrence.
Transitioning from Degarelix to Lupron can cause a dangerous PSA flare that needs to be avoided by adding an anti-androgen drug like Casodex prior to making the transition; not unlike when Lupron is started as an initial treatment.